Common misconceptions

Common mistake
Wrong: Purines and pyrimidines are both assembled on a ribose-5-phosphate scaffold from the start.
Right: Purines are assembled directly on ribose-5-phosphate (ring built on sugar), while pyrimidines are assembled as a free ring first and then attached to ribose-5-phosphate.
Pyrimidine synthesis builds the ring first (as orotic acid) in the cytoplasm and then attaches it to ribose-5-phosphate. Purine synthesis does the opposite — it starts with PRPP (phosphoribosyl pyrophosphate, a ribose-5-phosphate derivative) and builds the ring atom by atom directly on the sugar. This distinction matters because it explains why orotic acid accumulates in pyrimidine pathway disorders — it's an early free-ring intermediate. Conflating the two strategies leads to wrong answers on both synthesis mechanism and pathway disorder questions.
Common mistake
Wrong: Lesch-Nyhan syndrome is caused by adenosine deaminase deficiency.
Right: Lesch-Nyhan syndrome is caused by HGPRT deficiency, impairing purine salvage and causing hyperuricemia, self-mutilation, choreoathetosis, and intellectual disability.
Lesch-Nyhan is caused by HGPRT (hypoxanthine-guanine phosphoribosyltransferase) deficiency, which impairs the salvage of hypoxanthine and guanine back to usable nucleotides. Without salvage, purines get degraded to uric acid, causing hyperuricemia and gout. ADA deficiency causes a completely different phenotype — an immunodeficiency (SCID) — because ADA operates upstream in adenosine catabolism. Mixing these two up is the most common error on purine metabolism questions.
Common mistake
Wrong: ADA deficiency causes SCID by directly impairing lymphocyte receptor signaling.
Right: ADA deficiency causes accumulation of deoxyadenosine, which is toxic to lymphocytes (especially T cells), leading to SCID through lymphocyte destruction.
ADA (adenosine deaminase) normally converts adenosine and deoxyadenosine to inosine. When ADA is absent, deoxyadenosine accumulates and gets phosphorylated inside lymphocytes to dATP, which inhibits ribonucleotide reductase and triggers apoptosis. T cells are most vulnerable because they have high levels of the enzyme that makes dATP. This is a toxic metabolite mechanism — not a signaling defect — and understanding it explains why gene therapy replacing ADA restores immune function.
Common mistake
Wrong: Hereditary orotic aciduria and OTC deficiency are distinguished by orotic acid level alone.
Right: Both cause elevated orotic acid, but OTC deficiency also causes hyperammonemia and elevated BUN, while hereditary orotic aciduria has normal ammonia and presents with megaloblastic anemia unresponsive to B12/folate.
Orotic acid elevation alone cannot distinguish these two conditions. OTC (ornithine transcarbamylase) deficiency is a urea cycle disorder: carbamoyl phosphate spills into the pyrimidine pathway and drives orotic acid production, but the hallmark finding is hyperammonemia with elevated glutamine and low BUN. Hereditary orotic aciduria is a pyrimidine synthesis defect (UMP synthase deficiency) with normal ammonia and a characteristic megaloblastic anemia that does not respond to B12 or folate — it responds to uridine supplementation. Always check ammonia when you see orotic aciduria.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know that purines are assembled directly on ribose-5-phosphate (ring built on sugar), while pyrimidines are assembled as a free ring first and then attached to ribose-5-phosphate — the exam tests whether you understand the directional difference in these synthesis strategies.
  2. Know that Lesch-Nyhan syndrome results from HGPRT deficiency, which impairs purine salvage and causes hyperuricemia, self-mutilation, choreoathetosis, and intellectual disability — the exam asks you to identify the enzyme and explain the clinical constellation.
  3. Know that ADA deficiency causes SCID by allowing toxic accumulation of deoxyadenosine, which preferentially destroys T lymphocytes (and secondarily B cells) — the exam tests whether you understand the mechanism, not just the association.
  4. Know that both hereditary orotic aciduria and OTC deficiency elevate orotic acid, but OTC deficiency also produces hyperammonemia, while hereditary orotic aciduria presents with megaloblastic anemia unresponsive to B12 and folate — ammonia level and anemia type are the distinguishing clues the exam exploits.
  5. Know that allopurinol inhibits xanthine oxidase to reduce uric acid production and that it dangerously increases levels of 6-mercaptopurine (and azathioprine) when used together, because 6-MP is normally inactivated by xanthine oxidase — drug interaction questions on this are high-yield on USMLE Step 1.

Can you avoid these mistakes?

A 3-year-old boy presents with gouty tophi, choreoathetosis, and lip-biting self-injury. Uric acid is markedly elevated. What enzyme is deficient, what pathway is impaired, and why does uric acid accumulate specifically?
An infant presents with recurrent severe infections affecting both T and B cell counts. Enzyme assay reveals absent adenosine deaminase activity. Walk through the exact biochemical mechanism that explains why lymphocytes are destroyed — what metabolite accumulates, in what form, and what does it inhibit?
A patient with gout is started on allopurinol. They also take azathioprine for an autoimmune condition. Why is this combination potentially dangerous, and what dose adjustment is required?
A child presents with megaloblastic anemia that does not improve with B12 or folate supplementation. Urine organic acid testing shows elevated orotic acid. Serum ammonia is normal. What is the diagnosis, how does it differ mechanistically from OTC deficiency, and what is the treatment?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →